Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
The Innovative Health Initiative (IHI) builds on the previous Innovative Medicines Initiative (IMI2). IHI brings together diverse stakeholders (universities, companies large and small, and other health stakeholders) in collaborative projects. Call 1 covers topics on cancer, neurodegenerative diseases, and health data.
Característiques principals
  • Topic 1: An innovative decision-support system for improved care pathways for patients with neurodegenerative diseases and comorbidities
  • Topic 2: Next generation imaging and image-guided diagnosis and therapy for cancer
  • Topic 3: Personalised oncology: innovative people centred, multi-modal therapies against cancer
  • Topic 4: Access and integration of heterogeneous health data for improved healthcare in disease areas of high unmet public health need
    • Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
    • Carol Barnwell, cbarnwell@imim.es. Ext.: 1670
    • Marta López, mlopez4@imim.es Ext.: 1576
    Convocatòria (URL)
    https://www.ihi.europa.eu/apply-funding/ihi-call-1
    Informació addicional
    IHI call 1 is a single-stage call.
    Dotació
    Financial contribution from IMI2 JU from EUR 5.000.000 to 20.000.000 depending on the topic.
    Applicant consortia should ensure that out of the total project budget, at least 45 % needs to be covered by contributions provided by project participants

    Arxius

    Arxiu
    IHI_Call_1_final.pdf